In the subgroup analysis, we found no statistical evidence that the effect of the treatment type was significantly associated with age, tumour size, lymph node status, oestrogen and progesterone receptor status, proliferative rate, tumour grade or menopausal status (Table 3). The gene discussed is PGR; the disease is neoplasm.